课题基金 / 基金详情

项目摘要

项目成果

SEASON S-S WONG的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):这项SBIR第一阶段提案旨在开发和商业化一种便携式、易于使用的核酸制备系统,以便在低资源环境(LRS)下进行有效的分子诊断。该技术还将有助于监测艾滋病、疟疾和结核病等全球疾病患者的治疗反应。由于可靠和可重复的NA高质量样品制备过程对于大多数分子诊断分析的成功以及随后的治疗和恢复进程的监测至关重要,因此,如果在非传统或低资源的医疗保健环境中进行测试,有效的样品制备技术的可用性尤其重要。目前商业样品制备方法中的大多数过程都是劳动密集型的,需要特殊的仪器设备。尽管商业上可用的自动化系统可以进行广泛的样品处理,但在非中心实验室环境中使用它们是昂贵的。几项研究工作的重点是开发一种“进样,回答”微流控总分析系统(TAS)。虽然这些努力经常导致TAS平台具有令人印象深刻的分析能力,并代表着一个潜在的改变范式的长期解决方案,但它们仍然是一个活跃的研究领域,可能不适用于LRS环境。例如,这些系统的使用受到了限制,因为它们对仪器的持续需求对于LRS来说过于复杂和昂贵。为此,我们的合作者最近报道了一种便携式的、免离心机的、室温的核酸(NA)提取系统。这种核酸制备系统(或SNAP)只需要热稳定的试剂,因此该系统与LRS的储存和运输兼容。与其他需要立即洗脱捕获的NA的样品制备技术不同,样品稳定在可拆卸的色谱柱上,可以在护理时洗脱,也可以运输到中央实验室进行稍后分析。AI生物科学公司(AIBI)使用一项正在申请专利的多腔预充式注射器技术,建议显著减少SNAP技术的尺寸和重量,并减少执行提取所需的总动手时间。这个单一的预填充注射器将包含通过SNAP中的固相萃取(SPE)柱进行DNA/RNA提取所需的所有试剂。单个柱塞的动作可以顺序地将必要的试剂输送到该固相萃取柱以执行提取。在第一阶段,我们将演示从实际样品中有效地提取,并在15分钟或更短的时间内提供准备好的PCR和RT-PCR模板。分离的NA的产量和纯度预计将与商业试剂盒相匹配,后者需要更多的仪器和实际操作时间。我们还将评估LRS中实际使用的预填充试剂的长期稳定性。如果第一阶段的工作成功,我们将寻求在第二阶段开发一个低成本、全自动化和多样本的系统。
英文摘要
DESCRIPTION (provided by applicant): This SBIR Phase I proposal aims to develop and commercialize a portable, easy-to-use system for nucleic acid preparation for effective molecular diagnostics in low-resource settings (LRS). The technology will also aid in the monitoring of treatment response for patients of global diseases such as AIDS, malaria, and tuberculosis. Because a reliable and reproducible high-quality sample preparation process for NA is critical to the success of most molecular diagnostic assays and the subsequent treatment and monitoring of recovery progress, the availability of an effective sample preparation technology is especially important if the tests are performed in non-traditional or low-resource health care settings. Most processes in current commercial sample preparation methods are labor intensive and require special instrumentation. Although commercially available automated systems can perform extensive sample processing, they are expensive for use in non-central laboratory settings. Several research efforts have focused on the development of a "sample in, answer out" microfluidic total analysis system (¿TAS). While these efforts have often resulted in ¿TAS platforms with impressive analytical capabilities and represent a potentially paradigm-shifting long term solution, they remain an area of active research and may not be applicable to LRS settings. For instance, the use of these systems is inhibited by their continuing need for instrumentation that is too sophisticated and costly for LRS. To this end, a portable, centrifuge-free, room temperature nucleic acid (NA) extraction system has recently been reported by our collaborator. This system for nucleic acid preparation (or SNAP) requires only thermally stable reagents so the system is compatible with storage and transport in LRS. Unlike other sample preparation technology in which the captured NA needs to be eluted immediately, samples are stabilized on detachable cartridges, which can be eluted either at the point of care, or transported to a centralized laboratory for later analysis. Using a patent pending, multi-chamber, and prefilled syringe technology, AI Biosciences, Inc. (AIBI) proposes to significantly reduce the size and weight of the SNAP technology and to reduce the total hands-on time needed to perform an extraction. This single, pre-filled syringe will contain all the reagents required to conduct DNA/RNA extraction via the solid phase extraction (SPE) column in the SNAP. The actuation of a single plunger can sequentially deliver the necessary reagents to this SPE column to perform an extraction. In Phase I, we will demonstrate effective extraction from realistic samples and to deliver PCR and RT-PCR ready templates in 15 min or less. The yield and purity of the isolated NA are expected to match those obtained from commercially available kits that require far more instruments and hands-on time. We will also assess the long term stability of the pre-filled reagents for practical use in LRS. If the work in Phase I is successful we will seek to develop a low-cost, fully automated, and multi-sample system in Phase II.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid Point-of-Care Molecular Test for SARS-CoV-2 and Influenza A/B
  • 批准号:
    10484040
  • 项目类别:
  • 资助金额:
    $27.58万
  • 财政年份:
    2022
  • 负责人:
    SEASON S-S WONG
  • 依托单位:
An Ultrasensitive and Low-Cost p24 Antigen Test for the Early Detection of HIV
  • 批准号:
    10482574
  • 项目类别:
  • 资助金额:
    $29.96万
  • 财政年份:
    2022
  • 负责人:
    SEASON S-S WONG
  • 依托单位:
Rapid and Low- cost POC Assay for Zika Virus Diagnosis
  • 批准号:
    9254690
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2017
  • 负责人:
    SEASON S-S WONG
  • 依托单位:
Rapid and Ultrasensitive Direct Detection of RNA for Norovirus Gastroenteritis
  • 批准号:
    8833117
  • 项目类别:
  • 资助金额:
    $20.93万
  • 财政年份:
    2015
  • 负责人:
    SEASON S-S WONG
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: